PeptideStack
5.2kquestions
20kanswers
220users

Is there any published stability data for cagrilintide at minus 80 °C?

Asked 23 Jul 2026Modified 1 min agoViewed 2.3k times
16

Numbers first: cagrilintide · minus 80 °C.

I would rather be corrected now than propagate something wrong.

I am specifically not interested in a testimonial; I am interested in a measurement.

How well supported is this claim?

peptide-stability
peptide-stability

The chemistry of peptide degradation: deamidation, oxidation, hydrolysis, aggregation and fibrillation, and how temperature, pH, ionic strength,…

908 questions
storage
storage

Storage conditions and their evidence base: minus twenty degrees for powder, refrigerated for solution, protection from light, and what the…

701 questions
clinical-trials
clinical-trials

Reading the primary literature properly: estimands, intention-to-treat versus per-protocol, confidence intervals, absolute versus relative…

745 questions
amylin
amylin

Amylin and its analogues, most prominently cagrilintide, as a satiety mechanism orthogonal to incretin signalling. Includes the pharmacology of…

237 questions
shareeditfollowflag
LM
askedleonid_marchuk19k2723 Jul 2026
8Voting to keep this open — it is more specific than it first looks. – bufferline42 6 months ago
add a comment

4 Answers

Accepted answer first, then by votes
41

Accepted answer

Probably not at minus 80 °C specifically, because that is not where stability programmes take their readings. Accelerated work is conventionally run at 25 °C and 40 °C, with the refrigerated condition as the control, so minus 80 °C sits between or beyond the published points and what you will find is bracketing rather than a measurement. minus 80 °C is 85 kelvin below a refrigerator, and below the glass transition of a lyophilised cake the ten-degree rule of thumb stops applying at all — solid-state chemistry is not slow liquid chemistry, it is a different regime, and the failure modes that survive it are mechanical rather than chemical. Whatever you find, check what was measured before you use it: a paper reporting purity at minus 80 °C has not measured content, and the two fail at different rates for different reasons.

Answer first: the degradation pathways worth knowing are hydrolysis, deamidation, oxidation, aggregation and adsorption, and each has a different trigger and a different mitigation.

Adsorption onto glass and plastic is significant at low concentrations — micrograms per millilitre — and negligible at milligrams per millilitre. It is the usual explanation for an apparent loss in a dilute preparation.

Aggregation is physical: peptides unfold at air-liquid interfaces and associate. Shaking maximises that interface, which is why swirling and shaking produce visibly different outcomes on the same vial.

Aggregation at air-liquid interfaces is established from surface-tension and particle-count studies and is the basis for anti-agitation handling guidance.

At dilute concentrations, suspect adsorption before you suspect chemistry.

edited 15 Aug 2026 by marta_okonkwo — clarified the distinction between purity and content

shareimprove this answerflag
MO
answered · acceptedmarta_okonkwo190k25829 Jul 2026
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
16

The honest answer is that most reported "degradation" is adsorption and dilution error rather than chemistry.

Light exposure matters for tryptophan-containing sequences and for anything with a chromophore. Amber vials and a closed box are free mitigations.

A mass spectrum resolves most of this: minus eighteen is dehydration or succinimide, plus one is deamidation, plus sixteen is oxidation, and an unchanged mass with a shifted retention time is an isomer.

The caveat is that none of these pathways can be seen by looking at a vial, and a clear solution can be substantially degraded.

Sequence decides which pathways are even available. Check the residues.

edited 23 Aug 2026 by Dr_Ingrid_Baumgartner — added the citation requested in comments

shareimprove this answerflag
DB
answeredDr_Ingrid_Baumgartner73k5826 Jul 2026
Is there a reason to prefer minus eighty here, or is minus twenty genuinely enough? – deamidation_watch 5 months ago
2Worth adding that residual moisture predicts this better than any printed date. – nominal_ten 6 months ago
add a comment
10

The relevant point is that a mass shift of plus one dalton is deamidation and plus sixteen is oxidation, so degradation is often visible in a mass spectrum if anyone looks.

Hydrolysis cleaves the backbone, most readily at aspartate-proline and aspartate-glycine sequences, and is acid-catalysed. In a dry solid it barely proceeds at all.

Freeze-thaw cycling drives aggregation through concentration at the ice interface and pH shifts as buffer components crystallise out at different rates. Each cycle costs something.

Metal-catalysed oxidation of methionine is documented across peptide and protein formulations and is why chelators appear in some formulations.

Apparent loss in a dilute preparation is usually adsorption rather than degradation and is worth ruling out first.

Cold, dry, dark, still. Those four words cover most of the mitigation.

shareimprove this answerflag
TV
answeredten_mg_vial31k13825 Jul 2026
-3

Answering this needs the physical state, since a dry powder is protected from most of these and a solution is protected from none.

Deamidation converts asparagine or glutamine to the corresponding acid via a succinimide intermediate, adding one dalton. It is base-catalysed, accelerates above neutral pH and is the dominant aqueous pathway for many peptides.

Deamidation via the succinimide intermediate is well characterised, with sequence-dependent rates highest for asparagine-glycine motifs.

Sequence determines which pathways apply, so general statements are general.

A mass spectrum names the pathway. Plus one, plus sixteen, minus eighteen.

shareimprove this answerflag
DV
answeredDr_Bram_Verhoeven84k24828 Jul 2026
I have kept vials both ways for a year and this matches what I saw. – Dr_Elias_Weiss 4 months ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.